182 related articles for article (PubMed ID: 30187812)
21. The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure.
Jiang H; Xue Y; Wang Q; Pan J; Wu Y; Zhang J; Bai S; Wang Q; He G; Sun A; Wu D; Chen S
Leuk Res; 2012 Apr; 36(4):448-52. PubMed ID: 22047706
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of classic cytogenetic testing compared to fluorescence in situ hybridization in genetic diagnosis of 58 patients with myelodysplastic syndromes.
Skonieczka K; Duszeńko E; Wyrowińska E; Haus O
Pol Arch Med Wewn; 2009 Jun; 119(6):366-72. PubMed ID: 19694218
[TBL] [Abstract][Full Text] [Related]
23. A multimodal approach in the diagnosis of patients with hematopoietic disorders.
Mark HF; Gray Y; Mark Y; Khorsand J; Sikov W
Cancer Genet Cytogenet; 1999 Feb; 109(1):14-20. PubMed ID: 9973954
[TBL] [Abstract][Full Text] [Related]
24. [Application of fluorescence in situ hybridization technique to verify the clonalities of non-clonal cytogenetic abnormalities identified in Myelodysplastic syndrome].
Wang Z; Wang Y; Song W; Feng L; Gao L; Li Y; Huang X; Lai Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Mar; 40(3):257-262. PubMed ID: 36854397
[TBL] [Abstract][Full Text] [Related]
25. FISH analysis in addition to G-band karyotyping: utility in evaluation of myelodysplastic syndromes?
Yang W; Stotler B; Sevilla DW; Emmons FN; Murty VV; Alobeid B; Bhagat G
Leuk Res; 2010 Apr; 34(4):420-5. PubMed ID: 19800120
[TBL] [Abstract][Full Text] [Related]
26. [Karyotype studies of patients with a myelodysplastic syndrome].
Salamanchuk ZIa; Masliak ZV; Lozyns'ka MR; Vyhovs'ka IaI; Lohins'kyĭ VIe; Male P
Tsitol Genet; 1998; 32(1):43-8. PubMed ID: 9695251
[TBL] [Abstract][Full Text] [Related]
27. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
28. Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial.
Braulke F; Schulz X; Germing U; Schuler E; Platzbecker U; Nolte F; Hofmann WK; Giagounidis A; Götze K; Lübbert M; Schlenk RF; Schanz J; Bacher U; Ganser A; Büsche G; Letsch A; Schafhausen P; Bug G; Brümmendorf TH; Haas R; Trümper L; Shirneshan K; Haase D
Ann Hematol; 2017 Jun; 96(6):887-894. PubMed ID: 28374162
[TBL] [Abstract][Full Text] [Related]
29. Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.
Song Q; Chu Y; Yao Y; Peng M; Yang W; Li X; Huang S
Sci Rep; 2017 Sep; 7(1):10354. PubMed ID: 28871208
[TBL] [Abstract][Full Text] [Related]
30. Interphase FISH does not improve the detection of DEL(5q) and DEL(20q) in myelodysplastic syndromes.
Douet-Guilbert N; Herry A; LE Bris MJ; Guéganic N; Bovo C; Morel F; DE Braekeleer M
Anticancer Res; 2011 Mar; 31(3):1007-10. PubMed ID: 21498729
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal Abnormalities in Myelodysplastic Syndrome Patients in Upper Northern Thailand.
Phrommin S; Tantiworawit A; Rattanathammethee T; Puaninta C; Pangjaidee N; Aungsuchawan S; Bumroongkit K
Asian Pac J Cancer Prev; 2020 Mar; 21(3):639-645. PubMed ID: 32212788
[TBL] [Abstract][Full Text] [Related]
32. [Multiplex fluorescence in situ hybridization in detecting complex chromosomal aberrations in myelodysplastic syndromes].
Xiao B; Li JY; Pan JL; Ma L; Qiu HR; Wu YF; Xue YQ
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):513-6. PubMed ID: 16468325
[TBL] [Abstract][Full Text] [Related]
33. Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia.
Xu W; Li JY; Liu Q; Zhu Y; Pan JL; Qiu HR; Xue YQ
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e86-95. PubMed ID: 20089000
[TBL] [Abstract][Full Text] [Related]
34. Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms.
Seegmiller AC; Wasserman A; Kim AS; Kressin MK; Marx ER; Zutter MM; Mosse CA
Leuk Lymphoma; 2014 Mar; 55(3):601-5. PubMed ID: 23876099
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes.
Sánchez-Castro J; Marco-Betés V; Gómez-Arbonés X; García-Cerecedo T; López R; Talavera E; Fernández-Ruiz S; Ademà V; Marugan I; Luño E; Sanzo C; Vallespí T; Arenillas L; Marco Buades J; Batlle A; Buño I; Martín Ramos ML; Blázquez Rios B; Collado Nieto R; Vargas MT; González Martínez T; Sanz G; Solé F; ;
Leuk Lymphoma; 2015; 56(11):3183-8. PubMed ID: 25754580
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
Pitchford CW; Hettinga AC; Reichard KK
Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
[TBL] [Abstract][Full Text] [Related]
37. An analysis of complex chromosomal aberrations in seven cases of myelodysplastic syndromes by M-FISH and whole chromosome painting.
Li JY; Xiao B; Chen LJ; Pan JL; Xu W; Qiu HR; Li L; Xue YQ
Int J Hematol; 2008 Nov; 88(4):369-373. PubMed ID: 18991056
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization.
Wilkens L; Burkhardt D; Tchinda J; Büsche G; Werner M; Nolte M; Ganser A; Georgii A
Diagn Mol Pathol; 1999 Mar; 8(1):47-53. PubMed ID: 10408793
[TBL] [Abstract][Full Text] [Related]
39. Detection of complex karyotype in a myelodysplastic syndrome cell line (MUTZ-1) by metaphase fluorescence in situ hybridization.
Chen BA; Xia GH; Li JY; Xiao B; Shao ZY; Chen NN; Gao C; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):46-9. PubMed ID: 16584590
[TBL] [Abstract][Full Text] [Related]
40. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH.
Van Limbergen H; Poppe B; Michaux L; Herens C; Brown J; Noens L; Berneman Z; De Bock R; De Paepe A; Speleman F
Genes Chromosomes Cancer; 2002 Jan; 33(1):60-72. PubMed ID: 11746988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
